SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

SMS Pharmaceuticals - Quaterly Results

29 May 2024 Evaluate
The Turnover for the quarter ended March 2024 of Rs. 2457.98 millions increase by 64.49% from Rs. 1494.26 millions.Net profit surges 97.19% to Rs. 159.23  millions  from Rs. 80.75 millions in the quarter ended March 2024.Operating profit surged to 351.33 millions from the corresponding previous quarter of 245.03 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 2457.98 1494.26 64.49 7092.63 5220.51 35.86 7092.63 5220.51 35.86
Other Income 16.46 12.56 31.05 44.60 49.14 -9.24 44.60 49.14 -9.24
PBIDT 351.33 245.03 43.38 1213.04 595.88 103.57 1213.04 595.88 103.57
Interest 56.09 58.85 -4.69 234.57 219.13 7.05 234.57 219.13 7.05
PBDT 295.24 186.18 58.58 978.47 376.75 159.71 978.47 376.75 159.71
Depreciation 79.16 79.75 -0.74 315.16 321.25 -1.90 315.16 321.25 -1.90
PBT 216.08 106.43 103.03 663.31 55.50 1095.15 663.31 55.50 1095.15
TAX 56.85 25.68 121.38 169.07 14.65 1054.06 169.07 14.65 1054.06
Deferred Tax 10.55 25.13 -58.02 17.79 14.69 21.10 17.79 14.69 21.10
PAT 159.23 80.75 97.19 494.24 40.85 1109.89 494.24 40.85 1109.89
Equity 84.65 84.65 0.00 84.65 84.65 0.00 84.65 84.65 0.00
PBIDTM(%) 14.29 16.40 -12.84 17.10 11.41 49.84 17.10 11.41 49.84

SMS Pharmaceuticals Share Price

414.90 -5.70 (-1.36%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×